{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T02:00:48Z","timestamp":1780624848407,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejvs.2025.09.052","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T04:48:19Z","timestamp":1758948499000},"page":"975-984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lower Extremity Artery Endovascular Intervention Outcomes in Patients with Autoimmune Rheumatic Disease: an Analysis of the US Nationwide Inpatient Sample 2012 \u2013 2020"],"prefix":"10.1016","volume":"71","author":[{"given":"Yi-Fan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5593-1019","authenticated-orcid":false,"given":"Meng-Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2025.09.052_bib1","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#","article-title":"High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors","volume":"44","author":"del Rinc\u00f3n","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejvs.2025.09.052_bib2","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1161\/01.CIR.100.21.2124","article-title":"A tale of two diseases: atherosclerosis and rheumatoid arthritis","volume":"100","author":"Pasceri","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2025.09.052_bib3","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/circ.104.16.1876","article-title":"Atherosclerosis, autoimmunity, and systemic lupus erythematosus","volume":"104","author":"Thiagarajan","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2025.09.052_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11926-996-0064-9","article-title":"Atherosclerosis and systemic lupus erythematosus","volume":"2","author":"Urowitz","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ejvs.2025.09.052_bib5","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1253\/circj.CJ-08-0473","article-title":"Inflammatory cell infiltrates in vessels with different susceptibility to atherosclerosis in rheumatic and non-rheumatic patients: a controlled study of biopsy specimens obtained at coronary artery surgery","volume":"72","author":"Hollan","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.ejvs.2025.09.052_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1253\/circj.CJ-09-0274","article-title":"Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis","volume":"73","author":"Ku","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.ejvs.2025.09.052_bib7","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2025.09.052_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2012.05.013","article-title":"Endothelial dysfunction in rheumatic autoimmune diseases","volume":"224","author":"Murdaca","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejvs.2025.09.052_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejvs.2023.08.067","article-title":"Editor\u2019s Choice \u2013 European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of asymptomatic lower limb peripheral arterial disease and intermittent claudication","volume":"67","author":"Nordanstig","year":"2024","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1S","key":"10.1016\/j.ejvs.2025.09.052_bib10","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2025.09.052_bib11","doi-asserted-by":"crossref","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2025.09.052_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.23736\/S0392-9590.16.03759-7","article-title":"Results of surgical interventions for critical limb ischemia due to vasculitis or collagen-tissue related disease","volume":"36","author":"Yamamoto","year":"2017","journal-title":"Int Angiol"},{"key":"10.1016\/j.ejvs.2025.09.052_bib13","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.avsg.2013.06.041","article-title":"The influence of connective tissue disease in the management of lower limb ischemia","volume":"28","author":"Harries","year":"2014","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2025.09.052_bib14","first-page":"778","article-title":"Impact of systemic lupus erythematosus on in-hospital outcomes of peripheral artery disease\u2014insight from the National Inpatient Sample database","volume":"35","author":"Shah","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.ejvs.2025.09.052_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1055\/s-0035-1547516","article-title":"Preliminary report of endovascular treatment for critical limb ischemia patients with connective tissue disease: cases series and review of the literature","volume":"24","author":"Obara","year":"2015","journal-title":"Int J Angiol"},{"key":"10.1016\/j.ejvs.2025.09.052_bib16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/1346-8138.17334","article-title":"The treatment effect of endovascular therapy for chronic limb-threatening ischemia with systemic sclerosis","volume":"51","author":"Matsuda","year":"2024","journal-title":"J Dermatol"},{"key":"10.1016\/j.ejvs.2025.09.052_bib17","author":"Weiss"},{"key":"10.1016\/j.ejvs.2025.09.052_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.mayocp.2020.04.044","article-title":"Acute myocardial infarction in autoimmune rheumatologic disease: a nationwide analysis of clinical outcomes and predictors of management strategy","volume":"96","author":"Mohamed","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejvs.2025.09.052_bib19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/14397595.2014.966975","article-title":"Delayed wound healing after forefoot surgery in patients with rheumatoid arthritis","volume":"25","author":"Ishie","year":"2015","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ejvs.2025.09.052_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/acr.24596","article-title":"2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ejvs.2025.09.052_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/BOR.0000000000000389","article-title":"Infections in rheumatoid arthritis","volume":"29","author":"Atzeni","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ejvs.2025.09.052_bib22","article-title":"Chronic corticosteroid use as a risk factor for perioperative complications in patients undergoing total joint arthroplasty","volume":"4","author":"Kittle","year":"2020","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"10.1016\/j.ejvs.2025.09.052_bib23","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/M20-1594","article-title":"Risk for serious infection with low-dose glucocorticoids in patients with rheumatoid arthritis: a cohort study","volume":"173","author":"George","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejvs.2025.09.052_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/art.39399","article-title":"Comparative risk of hospitalized infection associated with biologic agents in rheumatoid arthritis patients enrolled in Medicare","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ejvs.2025.09.052_bib25","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/acr.24984","article-title":"Rheumatoid arthritis disease activity and hospitalized infection in a large US registry","volume":"75","author":"Yun","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.ejvs.2025.09.052_bib26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nrrheum.2014.37","article-title":"Rheumatoid arthritis: treating cardiovascular risk in RA requires multidisciplinary care","volume":"10","author":"Mankad","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ejvs.2025.09.052_bib27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamainternmed.2017.0059","article-title":"Variation in physician spending and association with patient outcomes","volume":"177","author":"Tsugawa","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejvs.2025.09.052_bib28","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1377\/hlthaff.2010.0394","article-title":"Medicare\u2019s bundled payment pilot for acute and postacute care: analysis and recommendations on where to begin","volume":"30","author":"Sood","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ejvs.2025.09.052_bib29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.ejvs.2025.09.052_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/ph14050403","article-title":"The relationship between pulmonary damage and peripheral vascular manifestations in systemic sclerosis patients","volume":"14","author":"Ruaro","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ejvs.2025.09.052_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2021.104064","article-title":"Digital ulcers in systemic sclerosis","volume":"50","author":"Hughes","year":"2021","journal-title":"Presse Med"},{"key":"10.1016\/j.ejvs.2025.09.052_bib32","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/rheumatology\/keq097","article-title":"Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions","volume":"49","author":"Amanzi","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejvs.2025.09.052_bib33","doi-asserted-by":"crossref","first-page":"658","DOI":"10.12968\/hmed.2019.80.11.658","article-title":"Raynaud\u2019s phenomenon","volume":"80","author":"Devgire","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.ejvs.2025.09.052_bib34","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2147\/JMDH.S295478","article-title":"The role of the multidisciplinary health care team in the management of patients with systemic sclerosis","volume":"15","author":"Farina","year":"2022","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.ejvs.2025.09.052_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000454","volume":"8","author":"Ajeganova","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ejvs.2025.09.052_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCINTERVENTIONS.108.788745","article-title":"Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry","volume":"1","author":"Maksimowicz-McKinnon","year":"2008","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ejvs.2025.09.052_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2022.03.002","article-title":"Global death burden and attributable risk factors of peripheral artery disease by age, sex, SDI regions, and countries from 1990 to 2030: results from the Global Burden of Disease study 2019","volume":"347","author":"Liu","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejvs.2025.09.052_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/1538574411418008","article-title":"Gender differences in outcomes of endovascular treatment of infrainguinal peripheral artery disease","volume":"45","author":"Gallagher","year":"2011","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.ejvs.2025.09.052_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0038-1636515","article-title":"Gender differences in peripheral vascular disease","volume":"35","author":"Schramm","year":"2018","journal-title":"Semin Intervent Radiol"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588425009396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588425009396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:23:34Z","timestamp":1780622614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588425009396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1078588425009396"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2025.09.052","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower Extremity Artery Endovascular Intervention Outcomes in Patients with Autoimmune Rheumatic Disease: an Analysis of the US Nationwide Inpatient Sample 2012 \u2013 2020","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2025.09.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Vascular Surgery. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}